Home » Marijuana & CBD » Page 3

Marijuana & CBD

Featured posts

Urgent: It’s time to protect public safety!

Support the association that supports you Dear NDASA Member and Industry Partner: Today, more than ever, we are standing at a crossroads and what happens next will shape the safety of our workplaces and communities for years to come. President Trump is reportedly...

Join the National Conversation on Marijuana Rescheduling

The National Drug & Alcohol Screening Association (NDASA) is hosting a national conversation to discuss the public safety implications surrounding the rescheduling of marijuana on Tuesday, December 16, at 4 p.m. (EST). This is a live streaming event open to the...

NDASA submits comments on DOT proposal to add fentanyl to drug testing panel

Submit your comments by Friday, October 17. NDASA has submitted its comments on the Procedures for Transportation Workplace Drug and Alcohol Testing Programs: Addition of Fentanyl to the Department of Transportation's Drug-Testing Panel; Harmonization with...

Podcast: Member's Memo

Updates on relevant industry news, compliance issues, regulatory changes and upcoming events.

All posts

Buyer beware: CBD, THC and drug testing

Buyer beware: CBD, THC and drug testing

Is CBD medicine or isn’t it? Is it safe? Can it impact a drug test result? Cannabis has been the focus of considerable debate, advocacy, and policy, generating both interest and misinformation. There is a great deal of uncertainty about cannabis and cannabinoid...